Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women
Samia Alhassan,Abdelgadir Elmugadam,Ghada A Elfadil,Nuha Abubaker,Elyasa M Elfaki,Alneil Hamza,Ezeldine K Abdalhabib,Tarig Karar
DOI: https://doi.org/10.2147/IJWH.S403347
2023-05-29
Abstract:Samia Alhassan, 1 Abdelgadir Elmugadam, 1 Ghada A Elfadil, 1 Nuha Abubaker, 1 Elyasa M Elfaki, 2 Alneil Hamza, 2 Ezeldine K Abdalhabib, 2 Tarig Karar 3, 4 1 Department of Clinical Chemistry, College of Medical Laboratory Science, Sudan University of Science and Technology, Khartoum, Sudan; 2 Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Al-Qurayyat, Saudi Arabia; 3 Clinical Laboratory Sciences Department, College of Applied Medical Sciences, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; 4 King Abdullah International Medical Research Centre, Riyadh, Saudi Arabia Correspondence: Elyasa M Elfaki, Department of Clinical Laboratory Sciences, College of Applied Medical Science, Jouf University, Omer bin Alkhattab Street, Al-Qurayyat, 77452, Saudi Arabia, Tel +966500769479, Email Background: Polycystic ovary syndrome (PCOS) is one of the most important contributing factors to infertility. The diagnosis of PCOS is not an easy procedure, as the signs and symptoms are heterogeneous and of undefined etiology. There are only a few published studies that address the diagnostic performance of anti-Müllerian hormone in diagnosis of PCOS in sub-Saharan Africa including Sudan. Objective: This study aims to assess anti-Müllerian hormone (AMH), luteinizing to follicle-stimulating hormone ratio (LH: FSH), total testosterone (TT), and prolactin (PRL) levels among PCOS. In addition, we determine if AMH can be used as a predictor of PCOS among Sudanese women. Methods: There were 600 women enrolled in this observational cross-sectional study, 300 of whom had PCOS, and 300 of whom healthy women; PCOS was diagnosed using the Rotterdam criteria. On days 2– 4 of the menstrual cycle, serum LH, FSH, AMH, TT, and PRL levels were measured for all participants. Diagnostic performance of these parameters for PCOS was determined by receiver operating characteristic (ROC) curve. Results: Significantly higher means among PCOS regarding their BMI, AMH; LH: FSH ratio; TT; PRL, whereas significantly inverse in FSH compared with normal ovulatory women. On ROC analysis, AMH had the largest operating characteristic curve at cut-off > 3.95 ng/mL; AUC = 0.999 with Youden's index 0.99%, followed by LH: FSH ratio at cut-off 0.749; AUC=0.932; Youden's index 0.813%, TT cut-off 0.82 mIU/L, AUC=0.852 with Youden's index 0.58, while PRL showed the lowest AUC=0.627 with cut-off 15.3 ng/mL, Youden's index was 0.18%, P. value< 0.001. Conclusions: Sudanese women with PCOS had higher serum AMH level, LH:FSH ratio, and TT level. Moreover, AMH level has better discriminative power and good diagnostic potency for the diagnosis of PCOS among Sudanese. Keywords: PCOS women, AMH, LH:FSH ratio, TT, PRL, Sudan Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder characterized by endocrine variation, the presence of ovarian cysts, and anovulation, all of which have a significant impact on a woman's life. 1,2 Disruption of reproductive hormones such as follicle-stimulating hormone (FSH), luteinizing hormone (LH), total testosterone (TT), and estrogen disrupts the normal menstrual cycle, resulting in oligomenorrhea and amenorrhea-like irregularities. PCOS is characterized by hyperandrogenism, menstrual irregularities, and ovarian cysts of varying sizes, despite significant individual variation. This multifactorial disorder improves initially in adolescents who are at high risk of developing multiple comorbidities, such as cardiovascular disorders, type II diabetes, obesity, infertility, endometrial dysplasia, and mental disorders. 3,4 The updated Rotterdam criteria, which were recently adopted by an international evidence-based PCOS guideline, are used to diagnose PCOS. 5,6 AMH is also a key hormonal indication in the development and maturation of ovarian follicles in PCOS women. 7 AMH overproduction inhibits follicular growth, resulting in ovarian dysfunction. Inadequate folliculogenesis is caused by an accumulation of androgens that inhibit normal androgen production. During the early gonadotropin phase, the increased androgens stimulate the primordial follicles formation and antral follicles proliferation. 8 The hypothalamic GnRH secretion will stimulate the pituitary's gonadotropin hormone secretion. LH acts on the LH receptor to stimulate the production of androgen in ovarian theca cells, while FSH stimulates the follicle growth in ovarian granulosa cells by converting androgens to estrogens. 9 It has been hypothesized that neuroendocrine system dysregulation leads to h -Abstract Truncated-
obstetrics & gynecology